Insider Transactions in Q4 2025 at Precision Biosciences Inc (DTIL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2025
|
Stanley Frankel Director |
BUY
Open market or private purchase
|
Direct |
2,700
+12.17%
|
$10,800
$4.7 P/Share
|
|
Dec 16
2025
|
Geno J Germano Director |
BUY
Open market or private purchase
|
Direct |
3,000
+11.16%
|
$12,000
$4.72 P/Share
|
|
Dec 15
2025
|
Melinda Brown Director |
BUY
Open market or private purchase
|
Direct |
1,381
+5.59%
|
$5,524
$4.97 P/Share
|
|
Nov 03
2025
|
Michael Amoroso President and CEO |
SELL
Open market or private sale
|
Direct |
3,409
-2.87%
|
$20,454
$6.49 P/Share
|
|
Nov 03
2025
|
Dario Scimeca General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
665
-2.3%
|
$3,990
$6.49 P/Share
|
|
Nov 03
2025
|
John Alexander Kelly Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,303
-1.66%
|
$7,818
$6.49 P/Share
|
|
Nov 02
2025
|
Michael Amoroso President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,444
+7.35%
|
-
|
|
Nov 02
2025
|
Dario Scimeca General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,835
+5.97%
|
-
|
|
Nov 02
2025
|
John Alexander Kelly Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,605
+4.39%
|
-
|